Novo Nordisk A/S, Søborg, Denmark.
Novo Nordisk A/S, Søborg, Denmark.
Mayo Clin Proc. 2023 Oct;98(10):1458-1468. doi: 10.1016/j.mayocp.2023.07.008. Epub 2023 Aug 9.
To compare clinical features of patients with obesity-related heart failure (HF) with preserved ejection fraction (HFpEF) with those of patients with similar body mass index (BMI) but no HF and to examine the association between degree of obesity and risk for hospitalizations.
This was a retrospective analysis of 22,750 adults from a large US electronic health care data set (January 1, 2012, through July 31, 2019), including 4975 with HFpEF. Baseline characteristics were compared between patients with HFpEF and a control group matched on BMI, age, sex, and year of BMI record. Risk of first hospitalization was analyzed in the HFpEF sample with negative binomial and Cox proportional hazards models, adjusted for baseline comorbidities.
Compared with controls without HF matched on BMI, age, sex, and year of BMI record, patients with HFpEF displayed worse kidney function, greater estimated plasma volume, and more cardiovascular comorbidities. Within the HFpEF cohort, patients with higher degree of obesity were younger and had fewer concomitant cardiovascular comorbidities than those with lower degree of obesity. The mean number of HF-related hospitalizations increased with higher degree of obesity (9.6 to 15.7/100 patient-years; P=.002), but higher degree of obesity was not associated with increased risk of non-HF-related hospitalizations.
Among persons with obesity, increasing cardiorenal dysfunction and volume overload differentiate those with HFpEF. Among persons with established HFpEF, those with higher degree of obesity are younger and have fewer cardiovascular comorbidities but display a unique increased risk of HF-related hospitalizations, even as risk for other hospitalizations is not different.
比较肥胖相关性射血分数保留心力衰竭(HFpEF)患者与具有相似体重指数(BMI)但无心力衰竭的患者的临床特征,并研究肥胖程度与住院风险之间的关系。
这是对来自美国大型电子医疗保健数据集中的 22750 名成年人(2012 年 1 月 1 日至 2019 年 7 月 31 日)进行的回顾性分析,其中包括 4975 名 HFpEF 患者。将 HFpEF 患者与 BMI、年龄、性别和 BMI 记录年份相匹配的对照组患者的基线特征进行比较。采用负二项和 Cox 比例风险模型分析 HFpEF 样本中首次住院的风险,同时调整基线合并症。
与 BMI、年龄、性别和 BMI 记录年份相匹配且无心力衰竭的对照组相比,HFpEF 患者的肾功能更差,估计的血浆体积更大,心血管合并症更多。在 HFpEF 队列中,与肥胖程度较低的患者相比,肥胖程度较高的患者年龄更小,同时伴有较少的心血管合并症。与较低程度肥胖的患者相比,较高程度肥胖的患者 HF 相关住院次数更多(9.6 至 15.7/100 患者年;P=.002),但较高程度肥胖与非 HF 相关住院风险增加无关。
在肥胖人群中,心肾功能障碍和容量超负荷的增加可区分 HFpEF 患者。在已确诊的 HFpEF 患者中,肥胖程度较高的患者年龄较小,心血管合并症较少,但 HF 相关住院的风险增加,尽管其他住院的风险没有差异。